Finding new treatments for kidney ciliopathies
Part of Genetic & congenital, Kidney & urinary clinical trials.
This study aims to find new treatment targets for nephronophthisis and related kidney ciliopathies. Researchers will collect blood and urine samples from people with these conditions, their healthy relatives, and other volunteers to better understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of nephronophthisis or a related kidney ciliopathy, or be a close relative, healthy volunteer, or someone with a different kidney disease.
- If you are a patient, you can join at any age, from birth onward.
- You need to sign a consent form (or have a parent or guardian sign for you).
- If you are a patient with a working kidney transplant, you can still join as long as you only give blood, not urine.
- You cannot be enrolled in another treatment study that started less than 30 days ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This study looks at how the body’s “Nrf2 response” works in people with autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand disease biology and future treatments by comparing kidney-related signals in ADPKD patients and healthy volunteers.
This trial studies kidney biopsy samples to learn how certain kidney cells repair damage. It may help find new treatments for kidney diseases.
This study looks at how the kidneys work in people with cystic fibrosis, especially those taking highly effective new treatments. It aims to understand kidney function in different groups, including those who are hospitalized frequently or rarely.
This observational study follows people early in autosomal dominant polycystic kidney disease (ADPKD) and also some healthy volunteers to learn how the kidneys work over time. It may help researchers understand early changes, which could guide future treatments.
This study collects medical information and samples from patients with podocytopathy—a type of autoimmune kidney disease that causes protein leakage into urine. Researchers will analyze your medical records and any blood or kidney tissue samples you've already had to better understand the disease and find better treatments.
Hear when a new Nephronophthisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.